SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-052362
Filing Date
2022-08-30
Accepted
2022-08-30 17:24:19
Documents
13
Period of Report
2022-08-25
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea165173-8k_somalogic.htm   iXBRL 8-K 44992
  Complete submission text file 0001213900-22-052362.txt   264461

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE slgc-20220825.xsd EX-101.SCH 4074
3 XBRL DEFINITION FILE slgc-20220825_def.xml EX-101.DEF 26767
4 XBRL LABEL FILE slgc-20220825_lab.xml EX-101.LAB 37000
5 XBRL PRESENTATION FILE slgc-20220825_pre.xml EX-101.PRE 25391
7 EXTRACTED XBRL INSTANCE DOCUMENT ea165173-8k_somalogic_htm.xml XML 5762
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 221215498
SIC: 8731 Services-Commercial Physical & Biological Research